Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Indra Thielen"'
Autor:
Heidrun Golla, Indra Thielen, Raymond Voltz, Dennis A. Eichenauer, Klaus Maria Perrar, Michael Hallek
Publikováno v:
Annals of Hematology. 98:2605-2607
Autor:
Peter Borchmann, Horst Mueller, Andreas Engert, Joerg H. Renno, Karolin Behringer, Teresa Halbsguth, Angelika Eibl, Helen Goergen, Johannes Rosenbrock, Michael Fuchs, Marietta Kuehr, M. von Wolff, Dennis A. Eichenauer, Volker Diehl, K. van der Ven, Indra Thielen, Katrin S. Reiners
Publikováno v:
Annals of Oncology. 31:1093
Autor:
Martin Vogelhuber, Boris Böll, Martin Sökler, Michael Pfreundschuh, Peter Borchmann, Michael Fuchs, Indra Thielen, Carolin Bürkle, Bastian von Tresckow, Dennis A. Eichenauer, Annette Plütschow, Michaela Feuring-Buske, Andreas Engert, Johannes Atta
Publikováno v:
British journal of haematology. 185(1)
About 30% of all Hodgkin lymphoma (HL) patients are ≥60 years old. As lenalidomide has promising single agent activity in multiple relapsed HL, we replaced bleomycin in ABVD with lenalidomide in this phase-I trial. Patients aged ≥60 years with ea
Autor:
Sascha Ansén, Hendrik Schwabe, Indra Thielen, Marianne Engels, Karl-Anton Kreuzer, Sebastian Brähler, Jürgen Wolf
Publikováno v:
European Journal of Haematology. 92:537-540
Isolated myeloid sarcoma is a rare presentation of acute myeloid leukemia. There are limited data available concerning the prognostic relevance and the right treatment strategy for this clinical scenario. Here, we report a case of acute myeloid leuke
Autor:
Peter Borchmann, Stefanie Kreissl, Helen Goergen, Michael Fuchs, Paul J Bröckelmann, Boris Böll, Diana Wongso, Annette Plütschow, Dennis A. Eichenauer, Indra Thielen, Karolin Behringer, B. von Tresckow, Teresa V Halbsguth, Andreas Engert
Publikováno v:
Leukemia. 30:1425-1427
Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group
Autor:
Dennis A. Eichenauer, Teresa Halbsguth, Horst Müller, Andreas Engert, Hiltrud Nisters-Backes, Indra Thielen, Thomas Schober, Karolin Behringer, Hans-Henning Flechtner, Peter Borchmann, Michael Fuchs, C. Brillant, Helen Görgen
Publikováno v:
British Journal of Cancer
Background: Health-related quality of life (HRQoL) comprises different domains of physical, mental, and social well-being. In this analysis, we focus on sexual quality of life in Hodgkin Lymphoma (HL) patients. Methods: Four-thousand one-hundred and
Autor:
Stefanie Kreissl, Peter Moosmann, Teresa Halbsguth, Andreas Engert, Indra Thielen, Julia Meissner, Hans-Henning Flechtner, Michael Fuchs, Corinne Brillant, Karolin Behringer, Oluwatoyin Shonukan, Volker Diehl, Helen Goergen, Horst Müller, Peter Borchmann, Jens Ulrich Rueffer, Richard Greil
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(36)
Purpose Cancer-related fatigue occurs frequently in patients with Hodgkin lymphoma (HL) and has a major impact on their quality of life. We hypothesized that severe fatigue (sFA) might have an impact on patients’ treatment outcome and social reinte
Autor:
Teresa Halbsguth, Bastian von Tresckow, Michael Fuchs, Peter Borchmann, Dennis A. Eichenauer, Jeremy Franklin, Achim Rothe, Andreas Engert, Indra Thielen, Beate Klimm, Stephanie Sasse, Volker Diehl, Boris Böll, Heinz Haverkamp, Karolin Behringer
Publikováno v:
Blood. 123(11)
Therapy-related acute myeloid leukemia and myelodysplastic syndromes (t-AML/MDS) represent severe late effects in patients treated for Hodgkin lymphoma (HL). Because more recent data are scarce, we retrospectively analyzed incidence, outcome, and ris
Autor:
Jorg H. Renno, Andreas Engert, Volker Diehl, Peter Borchmann, Michael Fuchs, Indra Thielen, Katrin van der Ven, Thomas Schober, Katrin S. Reiners, Martin Wiehlpütz, Michael von Wolff, Johannes Rosenbrock, Teresa Halbsguth, Karolin Behringer, Carsten Wessels, Helen Goergen, Horst Mueller, Angelika Eibl, Volker Stumpf, Marietta Kuehr
Publikováno v:
Behringer, Karolin; Mueller, Horst; Goergen, Helen; Thielen, Indra; Eibl, Angelika Diana; Stumpf, Volker; Wessels, Carsten; Wiehlpütz, Martin; Rosenbrock, Johannes; Halbsguth, Teresa; Reiners, Katrin S; Schober, Thomas; Renno, Jorg H; von Wolff, Michael; van der Ven, Katrin; Kuehr, Marietta; Fuchs, Michael; Diehl, Volker; Engert, Andreas and Borchmann, Peter (2013). Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. Journal of clinical oncology, 31(2), pp. 231-9. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2012.44.3721
Purpose To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy is needed. Therefore, we analyzed gonadal functions in survivors of HL. Patients and Methods
Autor:
Volker Diehl, Teresa Halbsguth, Johannes Rosenbrock, Angelika Eibl, Helen Goergen, K. van der Ven, Indra Thielen, Michael Fuchs, Peter Borchmann, Horst Mueller, Andreas Engert, Dennis A. Eichenauer, Joerg H. Renno, Karolin Behringer, Katrin S. Reiners, Marietta Kuehr, M. von Wolff
Publikováno v:
Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M; Diehl, V; Engert, A; Borchmann, P (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of oncology, 23(7), pp. 1818-25. Oxford: Oxford University Press 10.1093/annonc/mdr575
Background In the HD14 trial, 2× BEACOPPescalated+2× ABVD (2+2) has improved the primary outcome. Compared with 4× ABVD, this benefit might be compromised by more infertility in women. Therefore, we analyzed gonadal function and fertility. Patient